Apolipoprotein E Genotype e2: Neuroprotection and Its Limits ‌ Hyun Kim, Hyun Kim, Davangere P. Devanand, Davangere P. Devanand, Davangere P. Devanand, Scott Carlson, Terry E. Goldberg, Terry E. Goldberg, Terry E. Goldberg

Ստացեք ամբողջական տեքստը

Advancing Computerized Cognitive Training for MCI and Alzheimer's Disease in a Pandemic and Post-pandemic World ‌ Kaylee A. Bodner, Terry E. Goldberg, Terry E. Goldberg, D. P. Devanand, D. P. Devanand, P. Murali Doraiswamy

Ստացեք ամբողջական տեքստը

Efficacy of an online course in developing competency for prescribing balanced diet by medical students: A non - inferiority trial ‌ Zinia T Nujum, P Devanand, G Remya, U Anuja

Ստացեք ամբողջական տեքստը

Association of APOE e2 genotype with Alzheimer’s and non-Alzheimer’s neurodegenerative pathologies ‌ Terry E. Goldberg, Edward D. Huey, D. P. Devanand

Ստացեք ամբողջական տեքստը

Odor identification impairment and cholinesterase inhibitor treatment in Alzheimer's disease ‌ Jeffrey N. Motter, Xinhua Liu, Min Qian, Hannah R. Cohen, Davangere P. Devanand

Ստացեք ամբողջական տեքստը

Olfaction and neurocognition after COVID-19: a scoping review ‌ Brandon J. Vilarello, Patricia T. Jacobson, Jeremy P. Tervo, Nicholas A. Waring, David A. Gudis, David A. Gudis, Terry E. Goldberg, D. P. Devanand, D. P. Devanand, Jonathan B. Overdevest, Jonathan B. Overdevest

Ստացեք ամբողջական տեքստը

Models of depressive pseudoamnestic disorder ‌ Jongwoo Choi, Seonjoo Lee, Jeffrey N. Motter, Hyun Kim, Howard Andrews, P. Murali Doraiswamy, D. P. Devanand, Terry E. Goldberg

Ստացեք ամբողջական տեքստը

The benefits and costs of changing treatment technique in electroconvulsive therapy due to insufficient improvement of a major depressive episode ‌ Harold A. Sackeim, Joan Prudic, D.P. Devanand, Mitchell S. Nobler, Roger F. Haskett, Benoit H. Mulsant, Peter B. Rosenquist, William V. McCall

Ստացեք ամբողջական տեքստը

Disruption of early visual processing in amyloid-positive healthy individuals and mild cognitive impairment ‌ Daniel C. Javitt, Antigona Martinez, Pejman Sehatpour, Anna Beloborodova, Christian Habeck, Yunglin Gazes, Dalton Bermudez, Qolamreza R. Razlighi, D. P. Devanand, Yaakov Stern

Ստացեք ամբողջական տեքստը

Brain Amyloid Deposition and Longitudinal Cognitive Decline in Nondemented Older Subjects: Results from a Multi-Ethnic Population. ‌ Yian Gu, Qolamreza R Razlighi, Laura B Zahodne, Sarah C Janicki, Masanori Ichise, Jennifer J Manly, D P Devanand, Adam M Brickman, Nicole Schupf, Richard Mayeux, Yaakov Stern

Ստացեք ամբողջական տեքստը

Chemosensory deficits are best predictor of serologic response among individuals infected with SARS-CoV-2. ‌ Jonathan B Overdevest, Alexandria L Irace, Valeria Mazzanti, Eun Jeong Oh, Paule V Joseph, Davangere P Devanand, Zachary C Bitan, Eldad A Hod, David A Gudis, Codruta Chiuzan

Ստացեք ամբողջական տեքստը

Depression, Anxiety, and Neuropsychiatric Symptom Burden in a Longitudinal Cohort with Persistent Psychophysical Post-COVID Olfactory Dysfunction ‌ Tiana M. Saak, Jeremy P. Tervo, Brandon J. Vilarello, Patricia T. Jacobson, Francesco F. Caruana, Matthew D. A. Spence, Liam W. Gallagher, David A. Gudis, Jeffrey N. Motter, Davangere P. Devanand, Jonathan B. Overdevest

Ստացեք ամբողջական տեքստը

Deep learning improves utility of tau PET in the study of Alzheimer's disease ‌ James Zou, David Park, Aubrey Johnson, Xinyang Feng, Michelle Pardo, Jeanelle France, Zeljko Tomljanovic, Adam M. Brickman, Devangere P. Devanand, José A. Luchsinger, William C. Kreisl, Frank A. Provenzano, for the Alzheimer's Disease Neuroimaging Initiative

Ստացեք ամբողջական տեքստը

Antiviral therapy: Valacyclovir Treatment of Alzheimer’s Disease (VALAD) Trial: protocol for a randomised, double-blind,placebo-controlled, treatment trial ‌ Howard Andrews, D P Devanand, William C Kreisl, Qolamreza Razlighi, Anne Gershon, Yaakov Stern, Akiva Mintz, Thomas Wisniewski, Edward Acosta, Julianna Pollina, Mariasofia Katsikoumbas, Karen L Bell, Gregory H Pelton, Deborah Deliyannides, K M Prasad

Ստացեք ամբողջական տեքստը

Recovery rates of persistent post‐COVID‐19 olfactory dysfunction using psychophysical assessment: A longitudinal cohort study ‌ Jeremy P. Tervo, Patricia T. Jacobson, Brandon J. Vilarello, Tiana M. Saak, Francesco F. Caruana, Liam W. Gallagher, Joseph B. Gary, David A. Gudis, Paule V. Joseph, D.P. Devanand, Terry E. Goldberg, Jonathan B. Overdevest

Ստացեք ամբողջական տեքստը

Distinct and joint effects of low and high levels of Aβ and tau deposition on cortical thickness ‌ Seyed Hani Hojjati, Tracy A. Butler, Gloria C. Chiang, Christian Habeck, Arindam RoyChoudhury, Farnia Feiz, Jacob Shteingart, Siddharth Nayak, Sindy Ozoria, Antonio Fernández, Yaakov Stern, José A. Luchsinger, Davangere P. Devanand, Qolamreza R. Razlighi

Ստացեք ամբողջական տեքստը

Changes in QTc interval in the citalopram for agitation in Alzheimer's disease (CitAD) randomized trial. ‌ Lea T Drye, David Spragg, D P Devanand, Constantine Frangakis, Christopher Marano, Curtis L Meinert, Jacobo E Mintzer, Cynthia A Munro, Gregory Pelton, Bruce G Pollock, Anton P Porsteinsson, Peter V Rabins, Paul B Rosenberg, Lon S Schneider, David M Shade, Daniel Weintraub, Jerome Yesavage, Constantine G Lyketsos, CitAD Research Group

Ստացեք ամբողջական տեքստը

Development, initial validation, and application of a visual read method for [18F]MK‐6240 tau PET ‌ Joanna L. Shuping, Dawn C. Matthews, Katarzyna Adamczuk, David Scott, Christopher C. Rowe, William C. Kreisl, Sterling C. Johnson, Ana S. Lukic, Keith A. Johnson, Pedro Rosa‐Neto, Randolph D. Andrews, Koen Van Laere, Lindsay Cordes, Larry Ward, Claire L. Wilde, Jerome Barakos, Derk D. Purcell, Davangere P. Devanand, Yaakov Stern, Jose A. Luchsinger, Cyrille Sur, Julie C. Price, Adam M. Brickman, William E. Klunk, Adam L. Boxer, Sulantha S. Mathotaarachchi, Patrick J. Lao, Jeffrey L. Evelhoch

Ստացեք ամբողջական տեքստը